
Diagnostic testing is used to assess internal elements of your pet for the early detection of disease, or to confirm suspected diagnoses that have been based on symptoms that your pet has been presenting with.
The global Pets Diagnostic Tests market is projected to reach US$ 629.1 million in 2029, increasing from US$ 431 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pets Diagnostic Tests market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 39%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pets Diagnostic Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific, Inc.
IDEXX Laboratories, Inc.
Zoetis, Inc.
Virbac
Neogen Corporation
bioMérieux SA
Heska Corporation
IDvet
INDICAL Bioscience GmbH
Segment by Type
Clinical Biochemistry
Urinalysis
Immunodiagnostic
Hematology
Molecular Diagnostics
Segment by Application
Pets Clinical Pathology
Pets Bacteriology
Pets Parasitology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pets Diagnostic Tests report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Âé¶¹Ô´´ Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Âé¶¹Ô´´ Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Pets Diagnostic Tests Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Clinical Biochemistry
1.2.3 Urinalysis
1.2.4 Immunodiagnostic
1.2.5 Hematology
1.2.6 Molecular Diagnostics
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Pets Diagnostic Tests Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pets Clinical Pathology
1.3.3 Pets Bacteriology
1.3.4 Pets Parasitology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pets Diagnostic Tests Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Pets Diagnostic Tests Growth Trends by Region
2.2.1 Global Pets Diagnostic Tests Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pets Diagnostic Tests Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Pets Diagnostic Tests Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Pets Diagnostic Tests Âé¶¹Ô´´ Dynamics
2.3.1 Pets Diagnostic Tests Industry Trends
2.3.2 Pets Diagnostic Tests Âé¶¹Ô´´ Drivers
2.3.3 Pets Diagnostic Tests Âé¶¹Ô´´ Challenges
2.3.4 Pets Diagnostic Tests Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pets Diagnostic Tests Players by Revenue
3.1.1 Global Top Pets Diagnostic Tests Players by Revenue (2018-2023)
3.1.2 Global Pets Diagnostic Tests Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Pets Diagnostic Tests Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pets Diagnostic Tests Revenue
3.4 Global Pets Diagnostic Tests Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Pets Diagnostic Tests Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pets Diagnostic Tests Revenue in 2022
3.5 Pets Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Pets Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Pets Diagnostic Tests Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Pets Diagnostic Tests Breakdown Data by Type
4.1 Global Pets Diagnostic Tests Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Pets Diagnostic Tests Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Pets Diagnostic Tests Breakdown Data by Application
5.1 Global Pets Diagnostic Tests Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Pets Diagnostic Tests Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Pets Diagnostic Tests Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Pets Diagnostic Tests Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pets Diagnostic Tests Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Pets Diagnostic Tests Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pets Diagnostic Tests Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Pets Diagnostic Tests Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pets Diagnostic Tests Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Pets Diagnostic Tests Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pets Diagnostic Tests Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Pets Diagnostic Tests Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pets Diagnostic Tests Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Pets Diagnostic Tests Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Pets Diagnostic Tests Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Pets Diagnostic Tests Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Pets Diagnostic Tests Business (2018-2023)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 IDEXX Laboratories, Inc.
11.2.1 IDEXX Laboratories, Inc. Company Detail
11.2.2 IDEXX Laboratories, Inc. Business Overview
11.2.3 IDEXX Laboratories, Inc. Pets Diagnostic Tests Introduction
11.2.4 IDEXX Laboratories, Inc. Revenue in Pets Diagnostic Tests Business (2018-2023)
11.2.5 IDEXX Laboratories, Inc. Recent Development
11.3 Zoetis, Inc.
11.3.1 Zoetis, Inc. Company Detail
11.3.2 Zoetis, Inc. Business Overview
11.3.3 Zoetis, Inc. Pets Diagnostic Tests Introduction
11.3.4 Zoetis, Inc. Revenue in Pets Diagnostic Tests Business (2018-2023)
11.3.5 Zoetis, Inc. Recent Development
11.4 Virbac
11.4.1 Virbac Company Detail
11.4.2 Virbac Business Overview
11.4.3 Virbac Pets Diagnostic Tests Introduction
11.4.4 Virbac Revenue in Pets Diagnostic Tests Business (2018-2023)
11.4.5 Virbac Recent Development
11.5 Neogen Corporation
11.5.1 Neogen Corporation Company Detail
11.5.2 Neogen Corporation Business Overview
11.5.3 Neogen Corporation Pets Diagnostic Tests Introduction
11.5.4 Neogen Corporation Revenue in Pets Diagnostic Tests Business (2018-2023)
11.5.5 Neogen Corporation Recent Development
11.6 bioMérieux SA
11.6.1 bioMérieux SA Company Detail
11.6.2 bioMérieux SA Business Overview
11.6.3 bioMérieux SA Pets Diagnostic Tests Introduction
11.6.4 bioMérieux SA Revenue in Pets Diagnostic Tests Business (2018-2023)
11.6.5 bioMérieux SA Recent Development
11.7 Heska Corporation
11.7.1 Heska Corporation Company Detail
11.7.2 Heska Corporation Business Overview
11.7.3 Heska Corporation Pets Diagnostic Tests Introduction
11.7.4 Heska Corporation Revenue in Pets Diagnostic Tests Business (2018-2023)
11.7.5 Heska Corporation Recent Development
11.8 IDvet
11.8.1 IDvet Company Detail
11.8.2 IDvet Business Overview
11.8.3 IDvet Pets Diagnostic Tests Introduction
11.8.4 IDvet Revenue in Pets Diagnostic Tests Business (2018-2023)
11.8.5 IDvet Recent Development
11.9 INDICAL Bioscience GmbH
11.9.1 INDICAL Bioscience GmbH Company Detail
11.9.2 INDICAL Bioscience GmbH Business Overview
11.9.3 INDICAL Bioscience GmbH Pets Diagnostic Tests Introduction
11.9.4 INDICAL Bioscience GmbH Revenue in Pets Diagnostic Tests Business (2018-2023)
11.9.5 INDICAL Bioscience GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific, Inc.
IDEXX Laboratories, Inc.
Zoetis, Inc.
Virbac
Neogen Corporation
bioMérieux SA
Heska Corporation
IDvet
INDICAL Bioscience GmbH
Ìý
Ìý
*If Applicable.
